Aditxt (ADTX) EBITDA Margin (2022 - 2026)
Aditxt (ADTX) recorded quarterly EBITDA Margin of 132259.19% in Q1 2026, up 87.96% quarter-over-quarter from 1098725.65% in Q4 2025, and up 45246232.0% on a YoY basis from N/an in Q1 2025.
Aditxt (ADTX) EBITDA Margin (2022 - 2026) Analysis & Trends
Aditxt's EBITDA Margin history runs 5 years deep, the most recent figure standing at 132259.19% for Q1 2026.
- In Q1 2026, EBITDA Margin rose 45246232.0% year-over-year to 132259.19%; the TTM figure through Mar 2026 stood at 209570.34% (down 16929682.0% YoY), while the FY2025 annual figure was 1299933.43%, down 127379613.0% from the prior year.
- EBITDA Margin was 132259.19% for Q1 2026 at Aditxt, up from 1098725.65% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 1668.75% in Q3 2022 to a low of 1098725.65% in Q4 2025.
- Historically, EBITDA Margin has averaged 185614.3% across 5 years, with a median of 13497.11% in 2024.
- The sharpest annual moves came in 2025 and 2026: EBITDA Margin plunged 92074036 bps in 2025, then jumped 45246232 bps in 2026.
- A 5-year view of EBITDA Margin shows it stood at 4418.22% in 2022, then sank by 121 bps to 9780.05% in 2023, then sank by 1720 bps to 177985.29% in 2024, then sank by 517 bps to 1098725.65% in 2025, then surged by 88 bps to 132259.19% in 2026.
- The last three EBITDA Margin figures came in at 132259.19% (Q1 2026), 1098725.65% (Q4 2025), and 419870.32% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 | -132,259.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -132,259.19% |
| Dec 31, 2025 | -1,098,725.65% |
| Sep 30, 2025 | -419,870.32% |
| Jun 30, 2025 | -612,788.35% |
| Mar 31, 2025 | -584,721.51% |
| Dec 31, 2024 | -177,985.29% |
| Sep 30, 2024 | -68,588.24% |
| Jun 30, 2024 | -13,497.11% |
| Mar 31, 2024 | -14,477.47% |
| Dec 31, 2023 | -9,780.05% |
| Sep 30, 2023 | -6,502.91% |
| Jun 30, 2023 | -1,916.23% |
| Mar 31, 2023 | -2,647.21% |
| Dec 31, 2022 | -4,418.22% |
| Sep 30, 2022 | -1,668.75% |
| Jun 30, 2022 | -2,687.73% |
| Mar 31, 2022 | -2,908.96% |